UNION CITY, Calif.--(BUSINESS WIRE)--Celltheon today announced the commercial launch of its CHO-K1 based OmniCHO™ Transient Expression Kit, a breakthrough technology poised to transform preclinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback